好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Teleintervention Program for Multiple Sclerosis (MS) Mobility: Exercise with Transcranial Direct Current Stimulation (tDCS)
Neuro-rehabilitation
P18 - Poster Session 18 (5:30 PM-6:30 PM)
7-006

To establish feasibility of a teleintervention targeting mobility impairment with at-home exercise and transcranial direct current stimulation (tDCS) in people with multiple sclerosis (MS).

tDCS is a non-invasive brain stimulation technique that has the advantage to be delivered using a portable and handheld device, thus, it is increasingly being deployed through supervised self-administration in the home setting. In our previous study, we successfully piloted the in-clinic use of tDCS targeting the primary motor cortex to improve mobility in people with MS. To overcome the problems of access and adherence to exercise as a treatment for improving mobility, we piloted a telehealth intervention to provide a structured and accessible at-home program of daily exercise paired with our remotely-supervised tDCS (RS-tDCS) protocol.

People with MS (EDSS<6.5) were enrolled in a sham-controlled pilot study to receive 10x20-mins daily at-home sessions of either active or sham tDCS paired with moderate intensity cycling training delivered by a small seated elliptical machine (Cubii Pro). Stimulation was administered over the primary motor cortex (2.5 mA; anode C3/cathode FP2). All stimulation sessions were supervised in real-time. Measurements of gait velocity were collected at baseline and at treatment end.

Participants were n=5 people with MS and moderate-to-severe levels of disability (age:48±12; M/F:2/3; median EDSS:3.0). All sessions were completed successfully and without any safety issues. Adverse events (AEs) were minimal and consistent with the established tDCS literature with transitory sensations of warmth/tingling/itching under the electrode. The average change in gait velocity measured for the active tDCS participants showed similar mobility gains (Δgait velocity RS-tDCS vs. in-clinic tDCS: 0.24±0.10 m/s vs. 0.33±0.12 m/s) found in our onsite RCT.

RS-tDCS paired with exercise offers a widely accessible and easily scalable tool to address mobility impairments in those with MS and it is generalizable for use across a range of neurologic conditions.

Authors/Disclosures
Giuseppina Pilloni, PhD (NYU Grossman School of Medicine)
PRESENTER
Dr. Pilloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceragem.
No disclosure on file
Lauren B. Krupp, MD, FAAN (NYU Langone Medical Center) Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Leigh E. Charvet, PhD (NYU Langone) Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.